ResearcherUniversity of Alabama at BirminghamNo recent work listed
Eben Lloyd Rosenthal
Matched on ORCID iD 0000-0003-0294-5203; OpenAlex author ID A5086275218. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 3 papers · 2019: 1 paper · 2020: 1 paper
Papers 6
- Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalatio… Co-author DOI 10.1016/s2468-1253(20)30088-1↗
- Detection of visually occult metastatic lymph nodes using molecularly targeted fluorescent imaging during surgical resection of pancreatic cancer. Co-author DOI 10.1016/j.hpb.2018.11.008↗
- Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging. Last author DOI 10.1245/s10434-018-6453-2↗
- ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery. First author DOI 10.1245/s10434-018-6904-9↗
- Correction to: ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery. First author DOI 10.1245/s10434-018-7065-6↗
- Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy. Last author DOI 10.1097/cad.0b013e328349311e↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- George A. Poultsides · 5 shared papers, 2018–2020 · strength 0.48
- Paper ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery. DOI 10.1245/s10434-018-6904-9↗
- Paper Correction to: ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery. DOI 10.1245/s10434-018-7065-6↗
- Paper Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre… DOI 10.1016/s2468-1253(20)30088-1↗
- Willemieke S. F. J. Tummers · 4 shared papers, 2018–2019 · strength 0.38
- Paper ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery. DOI 10.1245/s10434-018-6904-9↗
- Paper Correction to: ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery. DOI 10.1245/s10434-018-7065-6↗
- Paper Detection of visually occult metastatic lymph nodes using molecularly targeted fluorescent imaging during surgical rese… DOI 10.1016/j.hpb.2018.11.008↗
- Alexander L. Vahrmeijer · 4 shared papers, 2018–2019 · strength 0.38
- Paper ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery. DOI 10.1245/s10434-018-6904-9↗
- Paper Correction to: ASO Author Reflections: Fluorescent-Guided Surgery to Augment Pancreatic Cancer Surgery. DOI 10.1245/s10434-018-7065-6↗
- Paper Detection of visually occult metastatic lymph nodes using molecularly targeted fluorescent imaging during surgical rese… DOI 10.1016/j.hpb.2018.11.008↗
- George Albert Fisher · 3 shared papers, 2018–2020 · strength 0.24
- Paper Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre… DOI 10.1016/s2468-1253(20)30088-1↗
- Paper Detection of visually occult metastatic lymph nodes using molecularly targeted fluorescent imaging during surgical rese… DOI 10.1016/j.hpb.2018.11.008↗
- Paper Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging. DOI 10.1245/s10434-018-6453-2↗
- Bert A. Bonsing · 2 shared papers, 2018–2019 · strength 0.15
- Sanjiv Sam Gambhir · 2 shared papers, 2018–2019 · strength 0.15
- Teri A. Longacre · 2 shared papers, 2018–2019 · strength 0.15
- Rutger‐Jan Swijnenburg · 2 shared papers, 2018–2019 · strength 0.15
- Guolan Lu · 1 shared paper, 2020 · strength 0.10
- Tong Zhou · 1 shared paper, 2011 · strength 0.02
- Kurt R. Zinn · 1 shared paper, 2011 · strength 0.02
- Hyunki Kim · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.